Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
Saltz LB, Rosen LS, Marshall JL, Belt RJ, Hurwitz HI, Eckhardt SG, Bergsland EK, Haller DG, Lockhart AC, Rocha Lima CM, Huang X, DePrimo SE, Chow-Maneval E, Chao RC, Lenz HJ.
Saltz LB, et al.
J Clin Oncol. 2007 Oct 20;25(30):4793-9. doi: 10.1200/JCO.2007.12.8637.
J Clin Oncol. 2007.
PMID: 17947727
Clinical Trial.